Recent advance in mesenchymal stem cells therapy for atopic dermatitis

Area of Science:

• Immunology
• Regenerative Medicine
• Dermatology

Background:

• Atopic dermatitis (AD) is a prevalent immune-mediated skin condition affecting humans and animals.
• Mesenchymal stem cells (MSCs) possess immunomodulatory properties and are sourced from various tissues.
• MSCs are being investigated for their therapeutic potential in immune-mediated disorders.

Purpose of the Study:

• To review current understanding of atopic dermatitis (AD) pathology.
• To summarize recent advances in preclinical and clinical studies of MSCs for AD treatment.
• To explore MSC-derived conditional media and exosomes as therapeutic agents for AD.

Main Methods:

• Literature review of recent research on AD pathology.
• Analysis of preclinical and clinical studies involving MSCs in AD models.
• Evaluation of studies on MSC-derived conditional media and exosomes for AD therapy.

Main Results:

• MSCs exhibit significant potential as a therapeutic strategy for immune-mediated skin diseases.
• Preclinical and clinical data suggest efficacy of MSCs in managing AD.
• MSC-derived products like conditional media and exosomes are emerging as promising therapeutic tools.

Conclusions:

• Mesenchymal stem cells (MSCs) offer a promising therapeutic avenue for atopic dermatitis (AD).
• Further research into MSCs, conditional media, and exosomes can advance AD treatment strategies.
• The immunomodulatory effects of MSCs are key to their potential in treating AD across species.